• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类17β-羟类固醇脱氢酶14的新见解:与甾体配体和强效非甾体抑制剂结合的首个晶体结构

New Insights into Human 17β-Hydroxysteroid Dehydrogenase Type 14: First Crystal Structures in Complex with a Steroidal Ligand and with a Potent Nonsteroidal Inhibitor.

作者信息

Bertoletti Nicole, Braun Florian, Lepage Mahalia, Möller Gabriele, Adamski Jerzy, Heine Andreas, Klebe Gerhard, Marchais-Oberwinkler Sandrine

机构信息

Institute for Pharmaceutical Chemistry, Philipps University Marburg , 35037 Marburg, Germany.

German Research Center for Environmental Health, Institute of Experimental Genetics, Genome Analysis Center, Helmholtz Zentrum München , 85764 Neuherberg, Germany.

出版信息

J Med Chem. 2016 Jul 28;59(14):6961-7. doi: 10.1021/acs.jmedchem.6b00293. Epub 2016 Jul 12.

DOI:10.1021/acs.jmedchem.6b00293
PMID:27362750
Abstract

17β-HSD14 is a SDR enzyme able to oxidize estradiol and 5-androstenediol using NAD(+). We determined the crystal structure of this human enzyme as the holo form and as ternary complexes with estrone and with the first potent, nonsteroidal inhibitor. The structures reveal a conical, rather large and lipophilic binding site and are the starting point for structure-based inhibitor design. The two natural variants (S205 and T205) were characterized and adopt a similar structure.

摘要

17β-羟基类固醇脱氢酶14是一种短链脱氢酶/还原酶(SDR)酶,能够利用烟酰胺腺嘌呤二核苷酸(NAD(+))氧化雌二醇和5-雄烯二醇。我们测定了这种人类酶的全酶形式以及与雌酮和第一种强效非甾体抑制剂形成的三元复合物的晶体结构。这些结构揭示了一个呈圆锥形、相当大且具有亲脂性的结合位点,是基于结构的抑制剂设计的起点。对两种天然变体(S205和T205)进行了表征,它们具有相似的结构。

相似文献

1
New Insights into Human 17β-Hydroxysteroid Dehydrogenase Type 14: First Crystal Structures in Complex with a Steroidal Ligand and with a Potent Nonsteroidal Inhibitor.人类17β-羟类固醇脱氢酶14的新见解:与甾体配体和强效非甾体抑制剂结合的首个晶体结构
J Med Chem. 2016 Jul 28;59(14):6961-7. doi: 10.1021/acs.jmedchem.6b00293. Epub 2016 Jul 12.
2
Structure-based design and profiling of novel 17β-HSD14 inhibitors.基于结构的新型 17β-HSD14 抑制剂的设计与评估。
Eur J Med Chem. 2018 Jul 15;155:61-76. doi: 10.1016/j.ejmech.2018.05.029. Epub 2018 May 22.
3
First Structure-Activity Relationship of 17β-Hydroxysteroid Dehydrogenase Type 14 Nonsteroidal Inhibitors and Crystal Structures in Complex with the Enzyme.17β-羟类固醇脱氢酶14型非甾体抑制剂的首次构效关系及与该酶复合物的晶体结构
J Med Chem. 2016 Dec 8;59(23):10719-10737. doi: 10.1021/acs.jmedchem.6b01436. Epub 2016 Nov 18.
4
Novel and potent 17beta-hydroxysteroid dehydrogenase type 1 inhibitors.新型强效17β-羟基类固醇脱氢酶1型抑制剂。
J Med Chem. 2005 Apr 21;48(8):2759-62. doi: 10.1021/jm049045r.
5
Structure-based design, synthesis and in vitro characterization of potent 17beta-hydroxysteroid dehydrogenase type 1 inhibitors based on 2-substitutions of estrone and D-homo-estrone.基于雌酮和 D-同型雌酮 2-取代物的 17β-羟甾脱氢酶 1 型抑制剂的基于结构的设计、合成和体外特性研究。
Bioorg Med Chem Lett. 2009 Dec 1;19(23):6740-4. doi: 10.1016/j.bmcl.2009.09.113. Epub 2009 Oct 3.
6
The derivation of a potential transition state for the reduction reaction catalysed by 17beta-hydroxysteroid dehydrogenase--an approximate representation of its active site for use in drug design and discovery.17β-羟基类固醇脱氢酶催化的还原反应潜在过渡态的推导——用于药物设计与发现的其活性位点的近似表示。
Biochem Biophys Res Commun. 2004 May 21;318(1):131-4. doi: 10.1016/j.bbrc.2004.03.190.
7
Substituted 6-phenyl-2-naphthols. Potent and selective nonsteroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1): design, synthesis, biological evaluation, and pharmacokinetics.取代的6-苯基-2-萘酚。强效且选择性的17β-羟基类固醇脱氢酶1型(17β-HSD1)非甾体抑制剂:设计、合成、生物学评价及药代动力学。
J Med Chem. 2008 Aug 14;51(15):4685-98. doi: 10.1021/jm800367k. Epub 2008 Jul 17.
8
Binary and ternary crystal structure analyses of a novel inhibitor with 17beta-HSD type 1: a lead compound for breast cancer therapy.新型 17β-HSD 型 1 抑制剂的二元和三元晶体结构分析:一种用于乳腺癌治疗的先导化合物。
Biochem J. 2009 Dec 10;424(3):357-66. doi: 10.1042/BJ20091020.
9
Inhibitors of 17β-hydroxysteroid dehydrogenase type 1, 2 and 14: Structures, biological activities and future challenges.17β-羟甾脱氢酶 1、2 和 14 型抑制剂:结构、生物活性和未来挑战。
Mol Cell Endocrinol. 2019 Jun 1;489:66-81. doi: 10.1016/j.mce.2018.10.001. Epub 2018 Oct 15.
10
Modification of estrone at the 6, 16, and 17 positions: novel potent inhibitors of 17beta-hydroxysteroid dehydrogenase type 1.雌酮在6、16和17位的修饰:新型强效1型17β-羟基类固醇脱氢酶抑制剂
J Med Chem. 2006 Feb 23;49(4):1325-45. doi: 10.1021/jm050830t.

引用本文的文献

1
Design and synthesis of 2-phenyl-1-benzo[]imidazole derivatives as 17β-HSD10 inhibitors for the treatment of Alzheimer's disease.作为用于治疗阿尔茨海默病的17β-羟基类固醇脱氢酶10(17β-HSD10)抑制剂的2-苯基-1-苯并咪唑衍生物的设计与合成
RSC Med Chem. 2025 Feb 21. doi: 10.1039/d4md00861h.
2
Crystallographic structure determination and analysis of a potential short-chain dehydrogenase/reductase (SDR) from multi-drug resistant Acinetobacter baumannii.多药耐药鲍曼不动杆菌中一种潜在的短链脱氢酶/还原酶(SDR)的晶体结构测定和分析。
PLoS One. 2023 Aug 24;18(8):e0289992. doi: 10.1371/journal.pone.0289992. eCollection 2023.
3
Virtual screening applications in short-chain dehydrogenase/reductase research.
虚拟筛选在短链脱氢酶/还原酶研究中的应用。
J Steroid Biochem Mol Biol. 2017 Jul;171:157-177. doi: 10.1016/j.jsbmb.2017.03.008. Epub 2017 Mar 9.